CLN (CLN) News
Follow CLN (CLN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Clariant Reports Q3 2026 Results, Reaffirms Full-Year Guidance
Clariant said revenue increased in the third quarter despite difficult market conditions, while operating profit and EBITDA declined amid margin pressure from product mix and raw material prices. It reaffirmed 2026 guida
EQUITY | Nov 03, 2026, 01:03 PM UTC
M
Celon Pharma reports Q2 net loss of 30.6 million zlotys
Celon Pharma reported a Q2 net loss of 30.6 million zlotys.
EQUITY | Sep 17, 2026, 04:47 AM UTC
L
APAC Realty Set to Benefit from Singapore Residential Sales — Market Talk
APAC Realty is set to benefit from a projected increase in Singapore residential transaction volumes in 4Q, says RHB Research's Vijay Natarajan in a note, citing a healthy project launch pipeline with visibility through
NEWS | Sep 14, 2026, 02:41 AM UTC
M
Celon Pharma gets positive opinion confirming Reduzek safety compliance
Celon Pharma SA said it received a positive opinion confirming Reduzek compliance with safety requirements. The company indicated the opinion is related to its GPW:CLN listing.
REGULATION | Sep 10, 2026, 12:16 PM UTC